Bremelanotide: Phase IIb data

In a double-blind, placebo-controlled Phase IIb (Study 16) trial in 726 non-diabetic patients, 7.5, 10, 12.5 and 15

Read the full 182 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE